GlassScriptPhysician profile
Thomas Joseph Pintar
NPI 1952343352
$163.96
in general payments reported to CMS, 2019-2025
7 companies · $55.66 in 2025
The $55.66 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.51 · 2020: $20.81 · 2021: $3.82 · 2024: $6.16 · 2025: $55.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.66 · Education: $6.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.66 |
| Education | $6.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $37.50 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Otsuka America Pharmaceutical, INC. | $33.31 | 2019 | |
| Genentech USA, INC. | $32.01 | 2019 | |
| Vifor Pharma, INC. | $20.81 | 2020 | |
| Novo Nordisk INC | $18.16 | 2025 | Ozempic |
| Novartis Pharmaceuticals Corporation | $12.19 | 2019 | |
| Travere Therapeutics, INC. | $9.98 | 2021-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Pintar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.